Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CALC
CALC | US
0.62
USD-0.03
-5.10%
CALC | US
About CALC
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
0.62
Open
0.64
High
0.65
Low
0.61
CalciMedica Inc. a clinical-stage biotechnology company focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis asparaginase-associated acute pancreatitis and acute kidney injury. The company is based in La Jolla California.
View LessCALC | US
Risk
130.6
Sharpe
-0.52
Luna's Score
42/100
Recommendation
Sell
Luna says (CALC | US)
What's Working
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
87.8%1 month
130.6%3 months
197.8%6 months
160.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.17
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.26
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-21.39M
MarketCap
6.64M
MarketCap(USD)
6.64M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-83.76
Short ratio
0.65
Short perc.
0.65
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.25
Range1M
0.42
Range3M
5.72
Volumes: Market Activity
Rel. volume
0.57
Price X volume
104.62K
